about
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines ...
Read More
3.41
-0.03
(-0.87%)
362.5K
XNAS Volume
XNAS 09 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Bullish
AC Immune SA Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..